Skip Nav Destination
1-20 of 84
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Christian Pecquet, Nicolas Papadopoulos, Thomas Balligand, Ilyas Chachoua, Amandine Tisserand, Gaëlle Vertenoeil, Audrey Nédélec, Didier Vertommen, Anita Roy, Caroline Marty, Harini Nivarthi, Jean-Philippe Defour, Mira El-Khoury, Eva Hug, Andrea Majoros, Erica Xu, Oleh Zagrijtschuk, Tudor E. Fertig, Daciana S. Marta, Heinz Gisslinger, Bettina Gisslinger, Martin Schalling, Ilaria Casetti, Elisa Rumi, Daniela Pietra, Chiara Cavalloni, Luca Arcaini, Mario Cazzola, Norio Komatsu, Yoshihiko Kihara, Yoshitaka Sunami, Yoko Edahiro, Marito Araki, Roman Lesyk, Veronika Buxhofer-Ausch, Sonja Heibl, Florence Pasquier, Violaine Havelange, Isabelle Plo, William Vainchenker, Robert Kralovics, Stefan N. Constantinescu
Blood (2023) 141 (8): 917–929.
Includes: Supplemental data
Gaps in the Assessment and Monitoring of Cardiovascular Risk and Psychological Burden in Polycythemia Vera: Landmark 2.0, a Worldwide Health Survey
Jean-Jacques Kiladjian, David M Ross, Laura Maria Fogliatto, Lynda Foltz, Lambert Busque, Zhijian Xiao, Florian H. Heidel, Michael Koehler, Giuseppe A. Palumbo, Massimo Breccia, Norio Komatsu, Keita Kirito, Blanca Xicoy Cirici, Joaquin Martinez-Lopez, Alicia Rovo, Cheryl Petruk, Mike Zuurman, Laura Mirams, Abigail McMillan, Gavin Harper, Claire Harrison
Blood (2022) 140 (Supplement 1): 12162–12164.
Surpass-ET Trial: A Phase 3, Open-Label, Multicenter, Randomized, Active-Controlled Study to Assess Pharmacokinetics and Compare the Efficacy, Safety, and Tolerability of P1101 Vs Anagrelide As Second Line Therapy for Essential Thrombocythemia
Ruben A. Mesa, Norio Komatsu, Harinder Gill, Jie Jin, Sung-Eun Lee, Hsin-An Hou, Toshiaki Sato, Albert Qin, Raymond Urbanski, Weichung Shih, Oleh Zagrijtschuk, Craig Zimmerman, Srdan Verstovsek
Blood (2021) 138 (Supplement 1): 1491.
Akira Honda, Kazuhiro Toyama, Yu Oyama, Kensuke Matsuda, Hideaki Mizuno, Akiko M Saito, Yoshio Katayama, Norio Komatsu, Mineo Kurokawa
Blood (2021) 138 (Supplement 1): 4192.
Therapeutic Potential of an Antibody Targeting the Cleaved Form of Mutant Calreticulin in Myeloproliferative Neoplasms
Yoshihiko Kihara, Marito Araki, PhD, Misa Imai, PhD, Yosuke Mori, MD, Mei Horino, Satoko Ogata, PhD, Syunpei Yoshikawa, Teppei Taguchi, Nami Masubuchi, PhD, Yo Mabuchi, PhD, Yinjie Yang, PhD, Yasutaka Fukuda, MDPhD, Soji Morishita, PhD, Takehiro Suzuki, PhD, Naoshi Domae, PhD, Motoyuki Shimonaka, PhD, Chihiro Akazawa, MD PhD, Akimichi Ohsaka, MD PhD, Norio Komatsu, MD PhD
Blood (2020) 136 (Supplement 1): 9–10.
MPL Overexpression Induces a High Level of Mutant-Calr/MPL Complex: A Novel Mechanism of Ruxolitinib Resistance in Myeloproliferative Neoplasms with Calr Mutations
Shunichiro Yasuda, MD, Satoru Aoyama, MD, Ryoto Yoshimoto, Student, Daisuke Watanabe, MD, PhD, Hiroki Akiyama, MD, PhD, Kouhei Yamamoto, Takeo Fujiwara, MD, Emiko Sakaida, MDPhD, Yoko Edahiro, MD PhD, Misa Imai, PhD, Marito Araki, PhD, Norio Komatsu, MD PhD, Norihiko Kawamata, MD, PhD
Blood (2020) 136 (Supplement 1): 16–17.
Concomitant Occurrence of Polyclonal Hematopoiesis and Cell-Autonomous Megakaryopoiesis in Triple-Negative Essential Thrombocythemia
Tadaaki Inano, MDPhD, Marito Araki, PhD, Soji Morishita, PhD, Misa Imai, PhD, Yoshihiko Kihara, Maho Okuda, PhD, Masafumi Ito, MD PhD, Satoshi Osaga, Yinjie Yang, PhD, Yoko Edahiro, MD PhD, Tomonori Ochiai, MDPhD, Kyohei Misawa, MDPhD, Yasutaka Fukuda, MDPhD, Akimichi Ohsaka, MD PhD, Norio Komatsu, MD PhD
Blood (2020) 136 (Supplement 1): 27–28.
A Phase 1 Study Evaluating Safety and Tolerability of Navitoclax Monotherapy in Japanese Patients with Myeloproliferative Neoplasms
Hirohiko Shibayama, MD PhD, Hirokazu Tanaka, MD PhD, Su-Peng Yeh, MD, Hui-Hua Hsiao, MD, Silpa Nuthalapati, PhD, Kota Ono, PhD, Kotaro Uehara, MS, Sumiko Okubo, MD PhD, Norio Komatsu, MD PhD
Blood (2020) 136 (Supplement 1): 15–16.
The Rationale, Design, and Baseline Characteristics of a Phase 2 Study to Evaluate the Safety and Efficacy of Ropeginterferon Alfa-2b (P1101) in Japanese Patients with Polycythemia Vera for Whom the Current Standard of Care Is Difficult to Apply
Keita Kirito, MD, Kazuya Shimoda, MD PhD, Katsuto Takenaka, MD PhD, Albert Qin, MD PhD, Oleh Zagrijtschuk, MD, Toshiaki Sato, MD PhD, Narihisa Miyachi, Hiroaki Kawase, Katsuya Yonezu, Norio Komatsu, MD PhD
Blood (2020) 136 (Supplement 1): 24–25.
Nami Masubuchi, PhD, Marito Araki, PhD, Kaho Shioiri, Sota Kitazawa, Yoshihiko Kihara, Yuta Ohira, Fumiko Nomura, Tadashi Matsuura, Norio Komatsu, MD PhD
Blood (2020) 136 (Supplement 1): 31.
Soji Morishita, PhD, Hajime Yasuda, MD PhD, Saya Yamawaki, Hideya Kawaji, PhD, Masayoshi Itoh, PhD, Yoko Edahiro, MD PhD, Misa Imai, PhD, Yasushi Kogo, PhD, Satoshi Tsuneda, PhD, Akimichi Ohsaka, MD PhD, Yoshihide Hayashizaki, MD PhD, Marito Araki, PhD, Norio Komatsu, MD PhD
Blood (2020) 136 (Supplement 1): 41.
Impact of COVID19 Pandemic on an International MPN Patient Population: Survey Results from 1560 MPN Patients
Jeanne M. Palmer, MD, Carolyn Mead-Harvey, MS, Claire Harrison, DM, FRCP, FRCPath, Amylou C. Dueck, PhD, Ryan Eckert, MS, Heidi E. Kosiorek, MS, Pablo Muxi, MD, Naveen Pemmaraju, MD, Guillermo Ruiz Arguelles, Alessandro M. Vannucchi, MD, Vikas Gupta, MD FRCP, FRCPath, John Mascarenhas, MD, Kerry Taylor, MBBS(Hons) FRACP FRCPA, Krisstina L. Gowin, DO, Holly L. Geyer, MD, Kazuya Shimoda, MD PhD, Jean-Jacques Kiladjian, MD PhD, Norio Komatsu, MD PhD, Grace Kam Li Shan, MBBS, Virginia Abello, MD, David Gomez-Almaguer, MD, Robyn M. Scherber, MD, Qian Jiang, MD, Xuelan Zuo, Jennifer Huberty, PhD, Lesley Anderson, MD, Blake T. Langlais, MS, Ann Brazeau, Michelle Woehrle, Michael J. Mauro, MD, Ruben Mesa, MD
Blood (2020) 136 (Supplement 1): 1–3.
Serum Soluble CD86, Still a Prognostic Factor in the Novel Agent Era in Multiple Myeloma Patients, Is Produced By Myeloma Cells with High CD86 Variant 3 Expression
Mariko Ishibashi, PhD, Ryosuke Kinoshita, MD, Koiti Inokuchi, MD PhD Prof., Hiroshi Handa, MD PhD, Makoto Sasaki, MD PhD, Norio Komatsu, MD PhD, Yoichi Imai, MD PhD, Norina Hiroike, MD PhD, Junji Tanaka, Sakae Tanosaki, MD PhD, Shigeki Ito, MD, PhD, Mika Sunakawa, MD, Toshio Asayama, MD, Yasuko Kuribayashi-hamada, MD, Rimpei Morita, MD PhD, Hideto Tamura, MD PhD
Blood (2019) 134 (Supplement_1): 4361.
Shoichiro Kato, MD, Takaaki Maekawa, MD PhD, Hiraku Ogata, MD, Yukiko Osawa, PhD, Kawasaki Kota, MD, Kohei Takada, MD, Takehiro Sone, MD, Keita Saito, MD, Takuya Izumi, MD, Shigeki Nagao, MD, Takano Kosuke, MD, Yosuke Okada, MD, Masahiro Teramoto, MD, Noriaki Tachi, MD, Toshikuni Kawamura, MD, Toshikatsu Horiuchi, MD, Ayako Kobayashi, MD PhD, Shinichi Kobayashi, MD PhD, Ken Sato, MD PhD, Kaori Endo-Umeda, PhD, Shigeyuki Uno, PhD, Soji Morishita, PhD, Marito Araki, PhD, Makoto Makishima, MD PhD, Norio Komatsu, MD PhD, Fumihiko Kimura, MD PhD
Blood (2019) 134 (Supplement_1): 4197.
Overexpression of MPL Causes Ruxolitinib-Resistance in Myeloproliferative Neoplasms with Calreticulin Frame-Shift Mutations
Shunichiro Yasuda, MD, Satoru Aoyama, MD, Ryoto Yoshimoto, Student, Watanabe Daisuke, MD, Hiroki Akiyama, MD, PhD, Yoshihiro Umezawa, MD, PhD, Ayako Nogami, MD PhD BPharm, Kouhei Yamamoto, Takeo Fujiwara, MD, Yoko Edahiro, MD PhD, Marito Araki, PhD, Norio Komatsu, MD PhD, Tetsuya Fukuda, MD PhD, Ayako Arai, MD PhD, Osamu Miura, MD, PhD, Norihiko Kawamata
Blood (2019) 134 (Supplement_1): 1690.
Baseline Mutational Status of Patients with Myelofibrosis and Anemia in the Realise Trial and Impact on Outcome
Haifa Kathrin Al-Ali, MD, Heinz Gisslinger, MD, Francesco Passamonti, MD, Lynda Foltz, MD FRCPC, David M Ross, MD PhD, Nicola Vianelli, MD, Alessandro M. Vannucchi, MD, Norio Komatsu, MD PhD, Pierre Zachée, Ranjan Tiwari, MSc, Evren Zor, MD, Shalini Chaturvedi, Geralyn Gilotti, MSc, Francisco Cervantes, MD
Blood (2019) 134 (Supplement_1): 2952.
Increased SLAMF7 high monocytes in myelofibrosis patients harboring JAK2 V617F provide a therapeutic target of elotuzumab
Takaaki Maekawa, Shoichiro Kato, Toshikuni Kawamura, Kohei Takada, Takehiro Sone, Hiraku Ogata, Keita Saito, Takuya Izumi, Shigeki Nagao, Kosuke Takano, Yosuke Okada, Noriaki Tachi, Masahiro Teramoto, Toshikatsu Horiuchi, Reina Hikota-Saga, Kaori Endo-Umeda, Shigeyuki Uno, Yukiko Osawa, Ayako Kobayashi, Shinichi Kobayashi, Ken Sato, Michihiro Hashimoto, Shinya Suzu, Kensuke Usuki, Soji Morishita, Marito Araki, Makoto Makishima, Norio Komatsu, Fumihiko Kimura
Blood (2019) 134 (10): 814–825.
Includes: Supplemental data
Secreted Mutant Calreticulins As Rogue Cytokines Trigger Thrombopoietin Receptor Activation Specifically in CALR Mutated Cells: Perspectives for MPN Therapy
Christian Pecquet, PhD, Thomas Balligand, MD, Ilyas Chachoua, PhD, Anita Roy, PhD, Gaelle Vertenoeil, MD, Didier Colau, PhD, Emanuel Fertig, MD, Caroline Marty, PhD, Harini Nivarthi, PhD, Jean-Philippe Defour, BPharm, PhD, Erica Xu, Eva Hug, PhD, Heinz Gisslinger, Bettina Gisslinger, Martin Schalling, MSc, Ilaria Carola Casetti, MD, Elisa Rumi, MD, Daniela Pietra, PhD, Chiara Cavalloni, MD, Luca Arcaini, MD, Mario Cazzola, Norio Komatsu, MD PhD, Yoshihiko Kihara, PhD, Yoshitaka Sunami, MD PhD, Yoko Edahiro, MD PhD, Marito Araki, PhD, Isabelle Plo, PhD, William Vainchenker, MD PhD, Robert Kralovics, PhD, Stefan N Constantinescu, MD
Blood (2018) 132 (Supplement 1): 4.
Overall Survival in Acquired Pure Red Cell Aplasia in Adults Following Immunosuppressive Therapy: Preliminary Results from the Nationwide Cohort Study (PRCA2016)
Naohito Fujishima, MD, Makoto Hirokawa, MD PhD, Kenichi Sawada, MD, Shinji Nakao, MD PhD, Yuji Yonemura, MD PhD, Akira Matsuda, MD, Norio Komatsu, MD PhD, Hideo Harigae, MD, Akiko Saito, MD, Kaoru Tohyama, MD, Itaru Matsumura, MD, Mineo Kurokawa, MD PhD, Shunya Arai, MD PhD, Kinuko Mitani, MD
Blood (2018) 132 (Supplement 1): 2593.
Comparison of the Clinical Outcomes of Nilotinib and Dasatinib Therapies in Newly Diagnosed Patients in the Chronic Phase of Chronic Myeloid Leukemia: A Retrospective Analysis
Noriyoshi Iriyama, MD PhD, Kei-Ji Sugimoto, Eriko Sato, MD PhD, Tomoiku Takaku, MD PhD, Michihide Tokuhira, Tomonori Nakazato, MD PhD, Maho Ishikawa, MD, Hiroyuki Fujita, MD PhD, Yuta Kimura, MD, Isao Fujioka, MD, Norio Asou, MD PhD, Masahiro Kizaki, MD PhD, Norio Komatsu, MD PhD, Yoshihiro Hatta, MD PhD, Tatsuya Kawaguchi, MD PhD
Blood (2018) 132 (Supplement 1): 4268.